Dyslipidemia in pregnancy

Area of Science:

• Obstetrics and Gynecology
• Cardiology
• Metabolic Disorders

Background:

• Emerging evidence links maternal lipid metabolism during pregnancy to adverse cardiometabolic outcomes.
• Pregnancy-associated dyslipidemia poses risks for both maternal and fetal vascular health.
• These effects may extend across generations, influencing long-term cardiovascular risk.

Purpose of the Study:

• To review current understanding of maternal lipid metabolism in pregnancy.
• To highlight the association between dyslipidemia and cardiometabolic dysfunction.
• To discuss the long-term vascular consequences for maternal-fetal dyads and offspring.

Main Methods:

• Literature review of recent studies on maternal cholesterol and triglyceride metabolism.
• Analysis of the link between disordered lipid profiles and cardiometabolic dysfunction.
• Synthesis of evidence on fetal and maternal vascular consequences.

Main Results:

• Poorly controlled maternal cholesterol and triglycerides are associated with significant fetal and maternal vascular issues.
• Cardiometabolic dysfunction during pregnancy has lasting effects on vascular health for mother and child.
• Potential for increased cardiovascular risk in subsequent generations.

Conclusions:

• Recognition of disordered maternal lipid metabolism is crucial.
• Early identification and management can mitigate long-term atherosclerotic burden.
• Understanding these mechanisms is vital for improving generational cardiovascular health.